Tinidazole impurity B

Hazard statements (CLP)

H312, H312+H332, H332, H341, H351

Code

Statements

H312

Harmful in contact with skin

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Acute toxicity, (Category 4) H332: Harmful if inhaled. Acute toxicity, (Category 4) H312: Harmful in contact with skin. Germ cell mutagenicity, H341: Suspected of causing genetic (Category 2) defects. Carcinogenicity, (Category 2) H351: Suspected of causing cancer.

2.2 Label elements

Labelling

Signal word

Warning Warning

Hazard statements

H312 + H332 Harmful in contact with skin or if inhaled. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. Reduced Labeling (<= 125 ml) H341 Suspected of causing genetic defects. H351 Suspected of causing cancer.

Precautionary statements

P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing dust. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.